Security key
H17182108
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 55,520,285
- Total 13F value
- $3,475,779,179
- Share change
- +300,880
- Put/Call ratio
- 122%
- SEC-reported price per share
- $62.60
- Number of holders
- 465
- Value change
- +$42,550,297
- Number of buys
- 225
- Number of sells
- 167
- Shares outstanding
- 96,232,072
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2023
Institutions
465
Top holders
10
CRSP full security history
Ownership snapshot
Full 13F holder table
CRISPR Therapeutics AG SEC filings
CRISPR Therapeutics AG company facts
Broader feeds
Ownership snapshot
Top reported holders of CRSP - CRISPR Therapeutics AG - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ARK Investment Management...
Disclosed value leader
ARK Investment Management...
Comparable rows
15/15
Latest evidence
30 Sep 2023
13F
Lead comparable stake: 7.4%
Showing 1-6 of 15 holder rows.
Quick read
ARK Investment Management LLC leads the comparable SEC ownership view at 7.4%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ARK Investment Management LLC's linked filing trail.
Comparable ownership
Top 5
ARK Investment Management LLC
7.4%
Capital International Investors
6.3%
T. Rowe Price Investment Manageme...
3.8%
Sumitomo Mitsui Trust Group, Inc.
3.6%
Amova Asset Management Americas, ...
3.6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ARK Investment Management LLC |
13F
Company
|
7.4%
|
$325,133,913
7,163,118 shares
|
— | 30 Sep 2023 |
| Capital International Investors |
13F
Company
|
6.3%
|
$276,221,390
6,085,512 shares
|
— | 30 Sep 2023 |
| T. Rowe Price Investment Management, Inc. |
13F
Company
|
3.8%
|
$165,757,000
3,651,833 shares
|
— | 30 Sep 2023 |
| Sumitomo Mitsui Trust Group, Inc. |
13F
Company
|
3.6%
|
$157,297,683
3,465,470 shares
|
— | 30 Sep 2023 |
| Amova Asset Management Americas, Inc. |
13F
Company
|
3.6%
|
$157,263,029
3,465,470 shares
|
— | 30 Sep 2023 |
| BlackRock Finance, Inc. |
13F
Company
|
2.8%
|
$123,152,601
2,713,210 shares
|
— | 30 Sep 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
465
Shares
55,520,285
Rows available
465
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
400
Q4 2023 holders
465
Holder diff
65
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 value | Q4 2023 value | Value change | Value Chg % |
|---|